Sumitomo Mitsui Trust Holdings Inc. lessened its holdings in HCP, Inc. (NYSE:HCP) by 7.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,017,547 shares of the real estate investment trust’s stock after selling 161,218 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc.’s holdings in HCP were worth $63,149,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also modified their holdings of HCP. Deutsche Bank AG raised its position in HCP by 1,073.7% in the 4th quarter. Deutsche Bank AG now owns 10,704,554 shares of the real estate investment trust’s stock worth $298,971,000 after purchasing an additional 9,792,507 shares during the period. Zimmer Partners LP purchased a new position in shares of HCP in the fourth quarter valued at about $230,959,000. Barrow Hanley Mewhinney & Strauss LLC increased its position in shares of HCP by 73.8% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,036,864 shares of the real estate investment trust’s stock valued at $392,050,000 after acquiring an additional 5,960,734 shares during the period. Cohen & Steers Inc. increased its position in shares of HCP by 35.0% in the fourth quarter. Cohen & Steers Inc. now owns 22,898,362 shares of the real estate investment trust’s stock valued at $639,551,000 after acquiring an additional 5,935,752 shares during the period. Finally, Norges Bank purchased a new position in shares of HCP in the fourth quarter valued at about $128,473,000. Institutional investors own 96.55% of the company’s stock.

In related news, Director Christine Garvey sold 3,405 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $29.80, for a total transaction of $101,469.00. Following the transaction, the director now owns 5,348 shares in the company, valued at $159,370.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.13% of the stock is owned by insiders.

HCP stock opened at $31.83 on Friday. HCP, Inc. has a 12-month low of $23.20 and a 12-month high of $32.23. The stock has a market capitalization of $15.21 billion, a price-to-earnings ratio of 17.49, a PEG ratio of 6.80 and a beta of 0.43. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.80 and a current ratio of 0.80.

HCP (NYSE:HCP) last released its quarterly earnings data on Wednesday, May 1st. The real estate investment trust reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. HCP had a net margin of 59.96% and a return on equity of 18.05%. The firm had revenue of $436.15 million for the quarter, compared to analysts’ expectations of $442.20 million. During the same quarter in the previous year, the company earned $0.48 earnings per share. The company’s revenue for the quarter was down 9.0% compared to the same quarter last year. As a group, equities analysts predict that HCP, Inc. will post 1.73 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 21st. Investors of record on Monday, May 6th were given a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 4.65%. The ex-dividend date was Friday, May 3rd. HCP’s dividend payout ratio is currently 81.32%.

A number of equities analysts have issued reports on the stock. TheStreet cut shares of HCP from a “b-” rating to a “c+” rating in a research report on Tuesday, May 7th. Morgan Stanley set a $32.00 price objective on shares of HCP and gave the company a “hold” rating in a research report on Thursday, March 28th. BMO Capital Markets restated a “buy” rating and issued a $33.00 price objective on shares of HCP in a research report on Wednesday, February 13th. Finally, Zacks Investment Research upgraded shares of HCP from a “sell” rating to a “hold” rating in a research report on Thursday, March 14th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $29.50.

TRADEMARK VIOLATION NOTICE: This report was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.watchlistnews.com/sumitomo-mitsui-trust-holdings-inc-has-63-15-million-position-in-hcp-inc-hcp/3022028.html.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Further Reading: Price-Sales Ratio

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.